Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM

ClinicalTrials.gov ID: NCT06897202

Public ClinicalTrials.gov record NCT06897202. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 10:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight, and Type 2 Diabetes Mellitus (VESPER-2)

Study identification

NCT ID
NCT06897202
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Metsera, a wholly owned subsidiary of Pfizer
Industry
Enrollment
133 participants

Conditions and interventions

Interventions

  • MET097 Injection Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 13, 2025
Primary completion
Jan 1, 2026
Completion
Mar 17, 2026
Last update posted
Apr 16, 2026

2025 – 2026

United States locations

U.S. sites
29
U.S. states
12
U.S. cities
26
Facility City State ZIP Site status
KUR Research Bessemer Alabama 35022
ProSciento, Inc. Chula Vista California 91911
Michael Roberts Opthamologist (Eye Exam) Glendale California 91204
Eye Treatment Center Long Beach California 90807
Collaborative Neuroscience Research, LLC Los Alamitos California 90720
Velocity Clinical Research, Los Angeles Los Angeles California 90017
Clinical Innovations, Inc dba CITrials Riverside California 92506
Synergy Healthcare Bradenton Florida 34209
Miami Eye Institute Hollywood Florida 33024
Research Centers of America Hollywood Florida 33024
ForCare Clinical Research Tampa Florida 33613
CenExel iResearch, LLC Decatur Georgia 30030
EmVenio Research Centre at PRIME Healthcare Riverdale Georgia 30274
CenExel iResearch, LLC Savannah Georgia 31405
Koch Family Medicine Clinical Research Morton Illinois 61550
Bioluminux Clinical Research Naperville Illinois 60540
EmVenio Research Centre at PRIME Healthcare Kansas City Kansas 66112
Eagle Eye Care Columbia Maryland 21045
KUR Research, LLC Columbia Maryland 21045
CBH Health, LLC. Gaithersburg Maryland 20877
Emvenio Research Garden City Michigan 48135
Velocity Clinical Research Omaha Nebraska 68134
Advocare Berlin Medical Associates Berlin New Jersey 08009
Hassman Research Institute Marlton New Jersey 08053
Onsite Clinical Solutions, LLC (Satellite site) Charlotte North Carolina 28277
Onsite Clinical Solutions, LLC Charlotte North Carolina 28277
EmVenio Research Centre at PRIME Healthcare Farmers Branch Texas 75234
Research Your Health Plano Texas 75093
Revival Research Institute, LLC Sherman Texas 75092

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06897202, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 16, 2026 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06897202 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →